Search

Search Constraints

You searched for: Author/Creator Cebon, Jonathon

Search Results

1. 612 Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. (9th November 2020)

2. 612 Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. (9th November 2020)

3. Advance care planning in patients with incurable cancer: study protocol for a randomised controlled trial. Issue 12 (1st December 2016)

4. Clinicopathological characteristics associated with BRAFK601E and BRAFL597 mutations in melanoma. (17th January 2016)

5. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. Issue 2 (30th July 2020)

6. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. Issue 2 (30th July 2020)

7. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. Issue 2 (30th July 2020)

8. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. Issue 2 (30th July 2020)

9. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. Issue 2 (30th July 2020)

10. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. Issue 2 (30th July 2020)